Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taha F S Ali

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Oxidative Medicine and Cellular Longevity|April 12, 2018
Cyclodextrin Enhances Corneal Tolerability and Reduces Ocular Toxicity Caused by DiclofenacHamdy Abdelkader, Zeinab Fathalla, Hossam Moharram, et al.
European Journal of Medicinal Chemistry|September 5, 2025
Targeting melanoma resistance: Novel oxindole and non-oxindole-based benzimidazole derivatives as potent dual inhibitors of BRAF<sup>V600E</sup> and ABL2 kinasesMohamed A S Badawy, Mohamed Abdel-Aziz, Hamdy M Abdel-Rahman, et al.
Drug Design, Development and Therapy|June 12, 2020
Applying Different Techniques to Improve the Bioavailability of Candesartan Cilexetil Antihypertensive DrugUsama Farghaly Aly, Hatem Abdel-Monsef Sarhan, Taha F S Ali, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Biologically Active Benzimidazole Hybrids as Cancer Therapeutics: Recent AdvancesMohamed A S Badawy, Stefan Bräse, Taha F S Ali, et al.
Drug Development Research|May 26, 2026
Discovery of Novel 5-Substituted-4-Allyl-1,2,4-Triazoles as Potential Nonsteroidal Anti-Inflammatory Agents via Downregulation of iNOS ExpressionSamar H Abbas, Asmaa S A Hammad, Dina M M H El-Kossi, et al.
Life Sciences|June 28, 2024
The protective role of two oxindole derivatives is mediated by modulating NLRP3/caspase-1 and PI3K/AKT pathways in a preclinical animal model of hepatic ischemia reperfusion injuryNardeen Eldafashi, Shaimaa Waaz, Taha F S Ali, et al.
European Journal of Medicinal Chemistry|December 7, 2013
1,2,4-Triazole/oxime hybrids as new strategy for nitric oxide donors: Synthesis, anti-inflammatory, ulceroginicity and antiproliferative activitiesGamal El-Din A A Abuo-Rahma, Mohamed Abdel-Aziz, Eman A M Beshr, et al.
Bioorganic & Medicinal Chemistry|May 14, 2013
New nitric oxide donating 1,2,4-triazole/oxime hybrids: synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activitiesMohamed Abdel-Aziz, Gamal El-Din A A Abuo-Rahma, Eman A M Beshr, et al.
BMC Chemistry|July 12, 2023
Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemiaHend A A Ezelarab, Taha F S Ali, Samar H Abbas, et al.
International Journal of Molecular Sciences|May 14, 2022
Novel Inhibitor for Downstream Targeting of Transforming Growth Factor-β Signaling to Suppress Epithelial to Mesenchymal Transition and Cell MigrationTsugumasa Toma, Hiroshi Tateishi, Kensaku Kawakami, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Oxidative Medicine and Cellular Longevity|April 12, 2018
Cyclodextrin Enhances Corneal Tolerability and Reduces Ocular Toxicity Caused by DiclofenacHamdy Abdelkader, Zeinab Fathalla, Hossam Moharram, et al.
European Journal of Medicinal Chemistry|September 5, 2025
Targeting melanoma resistance: Novel oxindole and non-oxindole-based benzimidazole derivatives as potent dual inhibitors of BRAF<sup>V600E</sup> and ABL2 kinasesMohamed A S Badawy, Mohamed Abdel-Aziz, Hamdy M Abdel-Rahman, et al.
Drug Design, Development and Therapy|June 12, 2020
Applying Different Techniques to Improve the Bioavailability of Candesartan Cilexetil Antihypertensive DrugUsama Farghaly Aly, Hatem Abdel-Monsef Sarhan, Taha F S Ali, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Biologically Active Benzimidazole Hybrids as Cancer Therapeutics: Recent AdvancesMohamed A S Badawy, Stefan Bräse, Taha F S Ali, et al.
Drug Development Research|May 26, 2026
Discovery of Novel 5-Substituted-4-Allyl-1,2,4-Triazoles as Potential Nonsteroidal Anti-Inflammatory Agents via Downregulation of iNOS ExpressionSamar H Abbas, Asmaa S A Hammad, Dina M M H El-Kossi, et al.
Life Sciences|June 28, 2024
The protective role of two oxindole derivatives is mediated by modulating NLRP3/caspase-1 and PI3K/AKT pathways in a preclinical animal model of hepatic ischemia reperfusion injuryNardeen Eldafashi, Shaimaa Waaz, Taha F S Ali, et al.
European Journal of Medicinal Chemistry|December 7, 2013
1,2,4-Triazole/oxime hybrids as new strategy for nitric oxide donors: Synthesis, anti-inflammatory, ulceroginicity and antiproliferative activitiesGamal El-Din A A Abuo-Rahma, Mohamed Abdel-Aziz, Eman A M Beshr, et al.
Bioorganic & Medicinal Chemistry|May 14, 2013
New nitric oxide donating 1,2,4-triazole/oxime hybrids: synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activitiesMohamed Abdel-Aziz, Gamal El-Din A A Abuo-Rahma, Eman A M Beshr, et al.
BMC Chemistry|July 12, 2023
Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemiaHend A A Ezelarab, Taha F S Ali, Samar H Abbas, et al.
International Journal of Molecular Sciences|May 14, 2022
Novel Inhibitor for Downstream Targeting of Transforming Growth Factor-β Signaling to Suppress Epithelial to Mesenchymal Transition and Cell MigrationTsugumasa Toma, Hiroshi Tateishi, Kensaku Kawakami, et al.
Pageof 5